Cost of Merck COVID-19 pill: How treatment compares to vaccines, monoclonal antibodies

  • 📰 Newsweek
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 52%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Merck's COVID-19 pill showed it prevented hospitalization or death in unvaccinated adults by 50 percent.

's vaccine cost the government about $40, Moderna's cost about $30 for full vaccination, and Johnson & Johnson's one-dose vaccination was only about $10 per dose, according to the Congressional Research Service.

Merck's oral antiviral pill is less expensive than monoclonal antibody treatments but more expensive than getting vaccinated against COVID-19. Above, employees walk past a Merck sign in front of the company's building on October 2, 2013, in Summit, New Jersey.More than 180 million Americans are fully vaccinated against COVID-19 but despite about 65 percent of the country's population being inoculated, hospitals continue to be overwhelmed.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 468. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravirMerck said it is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. what about the vaccine? Bitcoin is real only when you meet the right account manager to instruct you and guide you Since I met FredBrian17 my life has really turn around because of his skills in investing bitcoin with a good strategy plan, now I can afford what I couldn't few months ago Key word is experimental.
Source: CNN - 🏆 4. / 95 Read more »

Merck Seeks FDA Authorization for Antiviral COVID-19 PillDrugmaker Merck announced Monday that it submitted an application to the FDA for emergency use authorization of molnupiravir, an experimental antiviral COVID-19 treatment. That’s great 👍 Now the vaccine isn't enough, they got to make more money off us. From vaccine to pills......🤒 There they come again - 'emergency use'.......🤨 And where're the lab rats?🙄
Source: WebMD - 🏆 709. / 51 Read more »